HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Absarul Haque Selected Research

Blepharitis

12/2018Role of diagnostic factors associated with antioxidative status and expression of matrix metalloproteinases (MMPs) in patients with cancer therapy induced ocular disorders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Absarul Haque Research Topics

Disease

4Neoplasms (Cancer)
01/2020 - 01/2016
4Inflammation (Inflammations)
02/2019 - 01/2016
3Alzheimer Disease (Alzheimer's Disease)
01/2019 - 01/2016
2Ovarian Neoplasms (Ovarian Cancer)
03/2022 - 01/2020
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2019 - 01/2017
2Parkinson Disease (Parkinson's Disease)
01/2017 - 01/2016
1Colonic Neoplasms (Colon Cancer)
12/2021
1Cardiovascular Diseases (Cardiovascular Disease)
02/2019
1Retinal Degeneration
12/2018
1Glaucoma
12/2018
1Blepharitis
12/2018
1Macular Degeneration (Age-Related Maculopathy)
12/2018
1Cataract (Cataracts)
12/2018
1Pterygium
12/2018
1Retinitis Pigmentosa (Pigmentary Retinopathy)
12/2018
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2017
1Unstable Angina
01/2017
1Thalassemia
11/2016
1Leukemia
01/2016
1Nervous System Diseases (Neurological Disorders)
01/2016
1Rupture
01/2016
1Neuroinflammatory Diseases
01/2016
1Zoonoses
11/2014
1Candidiasis (Moniliasis)
05/2014
1Chromosome Aberrations (Chromosome Abnormalities)
01/2014
1Hemorrhagic Fever with Renal Syndrome (HFRS)
01/2011
1Wounds and Injuries (Trauma)
05/2005
1Burns
05/2005

Drug/Important Bio-Agent (IBA)

2DNA (Deoxyribonucleic Acid)IBA
12/2021 - 01/2014
2AntioxidantsIBA
12/2021 - 12/2018
2Glucose (Dextrose)FDA LinkGeneric
01/2019 - 05/2005
2diazonaphthalenedisulfonic acid (NDS)IBA
01/2017 - 01/2016
2Antiviral Agents (Antivirals)IBA
11/2014 - 01/2011
1multidrug resistance-associated protein 1IBA
03/2022
1NF-kappa B (NF-kB)IBA
12/2021
18-Hydroxy-2'-DeoxyguanosineIBA
12/2021
1Messenger RNA (mRNA)IBA
01/2020
1Fluorouracil (Carac)FDA LinkGeneric
01/2020
1PlatinumIBA
01/2020
1Carboplatin (JM8)FDA LinkGeneric
01/2020
1Biomarkers (Surrogate Marker)IBA
02/2019
1CholesterolIBA
02/2019
1Advanced Oxidation Protein Products (AOPP)IBA
02/2019
1Advanced Glycation End ProductsIBA
02/2019
1Triglycerides (Triacylglycerol)IBA
02/2019
1LDL Lipoproteins (beta Lipoproteins)IBA
02/2019
1HDL LipoproteinsIBA
02/2019
1LipidsIBA
02/2019
1Amyloid (Amyloid Fibrils)IBA
01/2019
1PPAR-gamma AgonistsIBA
01/2019
1Transcription Factors (Transcription Factor)IBA
01/2019
1LigandsIBA
01/2019
1Matrix Metalloproteinases (MMPs)IBA
12/2018
1EnzymesIBA
12/2018
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
12/2018
1Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2018
1Designed Ankyrin Repeat ProteinsIBA
01/2017
1Interleukin-18 (Interleukin 18)IBA
01/2017
1Ferritins (Ferritin)IBA
11/2016
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
11/2016
1Alkaline PhosphataseIBA
11/2016
1Alanine Transaminase (SGPT)IBA
11/2016
1Molecular Chaperones (Chaperone, Molecular)IBA
01/2016
1Complement System Proteins (Complement)IBA
01/2016
1Dopamine (Intropin)FDA LinkGeneric
01/2016
1Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2016
1Proteins (Proteins, Gene)FDA Link
01/2016
1CytokinesIBA
01/2016
1geldanamycinIBA
01/2016
1Cytochromes c (Cytochrome c)IBA
01/2016
1VaccinesIBA
11/2014
1Anti-Bacterial Agents (Antibiotics)IBA
05/2014
1Immunosuppressive Agents (Immunosuppressants)IBA
05/2014
1AgarIBA
05/2005

Therapy/Procedure

5Therapeutics
12/2018 - 01/2011
2Drug Therapy (Chemotherapy)
01/2020 - 12/2018
1Blood Transfusion (Blood Transfusions)
11/2016
1Catheters
05/2014